TY - JOUR
T1 - Pulmonary nontuberculous mycobacterial disease prevalence and clinical features
T2 - An emerging public health disease
AU - Winthrop, Kevin L.
AU - McNelley, Erin
AU - Kendall, Brian
AU - Marshall-Olson, Allison
AU - Morris, Christy
AU - Cassidy, Maureen
AU - Saulson, Ashlen
AU - Hedberg, Katrina
PY - 2010/10/1
Y1 - 2010/10/1
N2 - Rationale: Respiratory specimens with nontuberculous mycobacteria (NTM) are increasingly common; however, pulmonary disease prevalence is unknown. Objectives: To determine the disease prevalence, clinical features, and risk factors for NTM disease, and to examine the predictive value of the microbiologic criteria of the American Thoracic Society (ATS)/Infectious Diseases Society of America (IDSA) pulmonary NTM case definition for true NTM disease. Methods: We identified all Oregon residents during 2005-2006 with at least one respiratory mycobacterial isolate. From a population-based subset of these patients, we collected clinical and radiologic information and used the ATS/IDSA pulmonary NTM disease criteria to define disease. Measurements and Main Results: In the 2-year time period, 807 Oregonians hadone or more respiratory NTM isolates. Four hundred and seven (50%) resided within the Portland metropolitan region, among which 283 (70%) had evaluable clinical records. For those with records, 134 (47%) met ATS/IDSA pulmonary NTM disease criteria for a minimum overall 2-year period prevalence of 8.6/100,000 persons, and 20.4/100,000 in those at least 50 years of age within the Portland region. Case subjects were 66 years of age (median; range, 12-92 yr), frequently female (59%), and most with disease caused by Mycobacterium avium complex (88%). Cavitation (24.5%), bronchiectasis (16%), chronic obstructive pulmonary disease (28%), and immunosuppressive therapy (25.5%)were common. Eighty-six percent of patients meeting the ATS/IDSA microbiologic criteria for disease alsomet the full ATS/IDSA disease criteria. Conclusions: Respiratory NTM isolates frequently represent disease. Pulmonary NTM disease is not uncommon, particularly among elderly females. The ATS/IDSA microbiologic criteria are highly predictive of disease and could be useful for laboratory-based NTM disease surveillance.
AB - Rationale: Respiratory specimens with nontuberculous mycobacteria (NTM) are increasingly common; however, pulmonary disease prevalence is unknown. Objectives: To determine the disease prevalence, clinical features, and risk factors for NTM disease, and to examine the predictive value of the microbiologic criteria of the American Thoracic Society (ATS)/Infectious Diseases Society of America (IDSA) pulmonary NTM case definition for true NTM disease. Methods: We identified all Oregon residents during 2005-2006 with at least one respiratory mycobacterial isolate. From a population-based subset of these patients, we collected clinical and radiologic information and used the ATS/IDSA pulmonary NTM disease criteria to define disease. Measurements and Main Results: In the 2-year time period, 807 Oregonians hadone or more respiratory NTM isolates. Four hundred and seven (50%) resided within the Portland metropolitan region, among which 283 (70%) had evaluable clinical records. For those with records, 134 (47%) met ATS/IDSA pulmonary NTM disease criteria for a minimum overall 2-year period prevalence of 8.6/100,000 persons, and 20.4/100,000 in those at least 50 years of age within the Portland region. Case subjects were 66 years of age (median; range, 12-92 yr), frequently female (59%), and most with disease caused by Mycobacterium avium complex (88%). Cavitation (24.5%), bronchiectasis (16%), chronic obstructive pulmonary disease (28%), and immunosuppressive therapy (25.5%)were common. Eighty-six percent of patients meeting the ATS/IDSA microbiologic criteria for disease alsomet the full ATS/IDSA disease criteria. Conclusions: Respiratory NTM isolates frequently represent disease. Pulmonary NTM disease is not uncommon, particularly among elderly females. The ATS/IDSA microbiologic criteria are highly predictive of disease and could be useful for laboratory-based NTM disease surveillance.
KW - Bronchiectasis
KW - Disease prevalence
KW - Epidemiology
KW - Nontuberculous mycobacteria
KW - Pulmonary disease
UR - http://www.scopus.com/inward/record.url?scp=77958172574&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77958172574&partnerID=8YFLogxK
U2 - 10.1164/rccm.201003-0503OC
DO - 10.1164/rccm.201003-0503OC
M3 - Article
C2 - 20508209
AN - SCOPUS:77958172574
SN - 1073-449X
VL - 182
SP - 977
EP - 982
JO - American journal of respiratory and critical care medicine
JF - American journal of respiratory and critical care medicine
IS - 7
ER -